Calian Group (TSE:CGY – Free Report) had its target price cut by Ventum Financial from C$70.00 to C$68.00 in a research report report published on Wednesday,BayStreet.CA reports.
Other equities research analysts have also recently issued research reports about the company. CIBC decreased their target price on Calian Group from C$76.00 to C$63.00 in a research note on Friday, August 9th. Royal Bank of Canada cut their price target on Calian Group from C$75.00 to C$65.00 in a research note on Friday, August 9th. Finally, Cormark dropped their price objective on Calian Group from C$74.00 to C$73.00 in a report on Friday, August 9th. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of C$72.29.
Check Out Our Latest Analysis on Calian Group
Calian Group Price Performance
Calian Group Company Profile
Calian Group Ltd. provides business services and solutions in Canada and internationally. It operates through four segment: Advanced Technologies, Health, Learning, and IT and Cyber Solutions (ITCS). The company offers systems engineering, software development, integration design, embedded design, operational management and lifecycle support, modelling and simulation-enabled design, and research & development solutions and services; environmental and radiation protection, decommissioning and waste management, regulatory affairs and licensing, and emergency preparedness and training services; and sophisticated communication systems for the satellite industry, such as antennas, RF systems, decimator RF spectrum analyzers, in-orbit test systems, software defined solutions, operations and teleport services, transmitters, receivers, and modems.
Recommended Stories
- Five stocks we like better than Calian Group
- What is a buyback in stocks? A comprehensive guide for investors
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- The 3 Best Retail Stocks to Shop for in August
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- The Most Important Warren Buffett Stock for Investors: His Own
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.